HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emerging roles of Lipasin as a critical lipid regulator.

Abstract
Patients with metabolic syndrome are at high risk for developing atherosclerotic cardiovascular diseases and diabetes. In addition to total cholesterol, LDL-C and HDL-C, elevated plasma triglycerides (TG) are increasingly recognized as an independent risk factor for cardiovascular diseases. Recently 3 groups independently reported the identification and characterization of a novel blood lipid regulator, Lipasin/RIFL/ANGPTL8, which here is referred to as Lipasin for its lipoprotein lipase inhibition effect and for being a circulating factor denoted by 'in'. Being highly enriched in the liver, Lipasin is a hepatocyte-derived circulating factor that regulates plasma TG levels. Lipasin is nutritionally regulated, as its mRNA levels in liver and fat as well as its protein level in serum are reduced by fasting. Mice deficient for Lipasin have lower serum TG levels; conversely, its adenovirus-mediated overexpression increases serum TG levels, in part, through promoting ANGPTL3 cleavage, releasing its N-terminal domain that inhibits lipoprotein lipase. Lipasin sequence variations are associated with LDL-C and HDL-C concentrations in humans. Being lipogenic, Lipasin is highly induced during adipogenesis. Levels of Lipasin and ANGPTL4 show opposite changes in response to fasting or cold environment. Lipasin, a novel but atypical ANGPTL family member, is emerging as a critical lipid regulator and a potential drug target.
AuthorsRen Zhang, Abdul B Abou-Samra
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 432 Issue 3 Pg. 401-5 (Mar 15 2013) ISSN: 1090-2104 [Electronic] United States
PMID23415864 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • ANGPTL3 protein, human
  • ANGPTL4 protein, human
  • ANGPTL8 protein, human
  • Angiopoietin-Like Protein 3
  • Angiopoietin-Like Protein 4
  • Angiopoietin-Like Protein 8
  • Angiopoietin-like Proteins
  • Angiopoietins
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Peptide Hormones
  • Triglycerides
  • Lipoprotein Lipase
Topics
  • Adipogenesis
  • Angiopoietin-Like Protein 3
  • Angiopoietin-Like Protein 4
  • Angiopoietin-Like Protein 8
  • Angiopoietin-like Proteins
  • Angiopoietins (chemistry, metabolism)
  • Animals
  • Cholesterol, HDL (blood, metabolism)
  • Cholesterol, LDL (blood, metabolism)
  • Cold Temperature
  • Humans
  • Lipid Metabolism
  • Lipoprotein Lipase (antagonists & inhibitors)
  • Metabolic Syndrome (complications, genetics, metabolism)
  • Mice
  • Peptide Hormones (chemistry, genetics, metabolism)
  • Protein Conformation
  • Triglycerides (blood, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: